← FDA Drug Approvals (Drugs@FDA)

METHYLNALTREXONE BROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LLC · Approved 2024-08-26

Drug application

FDA Application #

ANDA208112

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHYLNALTREXONE BROMIDE

Generic name

Methylnaltrexone Bromide

Active ingredients

METHYLNALTREXONE BROMIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

ACTAVIS LLC

First approval

2024-08-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown